Holen Sie sich die Stockscreener-App
4.20
2.10%
-0.09
Handel nachbörslich:
4.20
Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
19.03%
4.774
|
5.8964 | 5.1796 | 5.4085 | 5.732 |
| Depreciation and Amortization |
0.00%
0.00457
|
0.00457 | - | - | - |
| Operating Income/Loss |
19.03%
-4.774
|
-5.8964 | -5.1796 | -5.4085 | -5.732 |
| Income/Loss From Continuing Operations Before Tax |
22.78%
-4.5368
|
-5.8752 | -4.5057 | -4.9595 | -5.4408 |
| Income/Loss From Continuing Operations After Tax |
22.78%
-4.5368
|
-5.8752 | -4.5057 | -4.9595 | -5.4408 |
|
Net Income/Loss
|
22.78%
-4.5368
|
-5.8752 | -4.5057 | -4.9595 | -5.4408 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
147.56K%
10.78
|
0.0073 | 10.76 | 10.76 | 10.74 |
| Diluted Average Shares |
147.56K%
10.78
|
0.0073 | 10.76 | 10.76 | 10.74 |
| Basic Earnings Per Share |
22.22%
-0.42
|
-0.54 | -0.42 | -0.46 | -0.51 |
| Diluted Earnings Per Share |
22.22%
-0.42
|
-0.54 | -0.42 | -0.46 | -0.51 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):